nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetaminophen—PTGS2—thyroid cancer	0.342	1	CbGaD
Acetaminophen—UGT1A9—Sorafenib—thyroid cancer	0.123	0.309	CbGbCtD
Acetaminophen—UGT1A1—Sorafenib—thyroid cancer	0.1	0.253	CbGbCtD
Acetaminophen—CYP2C8—Sorafenib—thyroid cancer	0.0294	0.0741	CbGbCtD
Acetaminophen—CYP1A2—Sorafenib—thyroid cancer	0.0228	0.0574	CbGbCtD
Acetaminophen—CYP2C9—Sorafenib—thyroid cancer	0.0205	0.0517	CbGbCtD
Acetaminophen—ABCB1—Sorafenib—thyroid cancer	0.0199	0.0502	CbGbCtD
Acetaminophen—CYP3A4—Vandetanib—thyroid cancer	0.0198	0.0499	CbGbCtD
Acetaminophen—CYP2D6—Sorafenib—thyroid cancer	0.0188	0.0473	CbGbCtD
Acetaminophen—ABCB1—Doxorubicin—thyroid cancer	0.0121	0.0304	CbGbCtD
Acetaminophen—CYP3A4—Sorafenib—thyroid cancer	0.0119	0.0301	CbGbCtD
Acetaminophen—CYP2D6—Doxorubicin—thyroid cancer	0.0114	0.0287	CbGbCtD
Acetaminophen—CYP3A4—Doxorubicin—thyroid cancer	0.00724	0.0182	CbGbCtD
Acetaminophen—SULT1A1—neck—thyroid cancer	0.00357	0.147	CbGeAlD
Acetaminophen—SULT1A1—trachea—thyroid cancer	0.00215	0.0886	CbGeAlD
Acetaminophen—SULT2A1—head—thyroid cancer	0.0019	0.0783	CbGeAlD
Acetaminophen—CNR1—thyroid gland—thyroid cancer	0.00184	0.0762	CbGeAlD
Acetaminophen—SULT1A1—thyroid gland—thyroid cancer	0.0017	0.0701	CbGeAlD
Acetaminophen—SULT1A1—head—thyroid cancer	0.00151	0.0622	CbGeAlD
Acetaminophen—SULT2A1—lymph node—thyroid cancer	0.00133	0.0548	CbGeAlD
Acetaminophen—TRPV1—head—thyroid cancer	0.00133	0.0548	CbGeAlD
Acetaminophen—SULT1E1—lymph node—thyroid cancer	0.00122	0.0506	CbGeAlD
Acetaminophen—CNR1—lymph node—thyroid cancer	0.00115	0.0473	CbGeAlD
Acetaminophen—SULT1A1—lymph node—thyroid cancer	0.00105	0.0436	CbGeAlD
Acetaminophen—Muscle spasms—Sorafenib—thyroid cancer	0.00051	0.00357	CcSEcCtD
Acetaminophen—Injection site pain—Doxorubicin—thyroid cancer	0.000508	0.00355	CcSEcCtD
Acetaminophen—Abdominal pain—Vandetanib—thyroid cancer	0.000507	0.00355	CcSEcCtD
Acetaminophen—Body temperature increased—Vandetanib—thyroid cancer	0.000507	0.00355	CcSEcCtD
Acetaminophen—Blood disorder—Doxorubicin—thyroid cancer	0.000497	0.00347	CcSEcCtD
Acetaminophen—Liver injury—Doxorubicin—thyroid cancer	0.000493	0.00345	CcSEcCtD
Acetaminophen—Anaemia—Sorafenib—thyroid cancer	0.00049	0.00343	CcSEcCtD
Acetaminophen—Oliguria—Epirubicin—thyroid cancer	0.000487	0.0034	CcSEcCtD
Acetaminophen—Angioedema—Sorafenib—thyroid cancer	0.000485	0.00339	CcSEcCtD
Acetaminophen—Dyskinesia—Epirubicin—thyroid cancer	0.000477	0.00334	CcSEcCtD
Acetaminophen—Leukopenia—Sorafenib—thyroid cancer	0.000475	0.00332	CcSEcCtD
Acetaminophen—CYP1A1—trachea—thyroid cancer	0.00047	0.0194	CbGeAlD
Acetaminophen—Cough—Sorafenib—thyroid cancer	0.000463	0.00324	CcSEcCtD
Acetaminophen—Asthenia—Vandetanib—thyroid cancer	0.00046	0.00322	CcSEcCtD
Acetaminophen—Hypertension—Sorafenib—thyroid cancer	0.000458	0.0032	CcSEcCtD
Acetaminophen—Coordination abnormal—Epirubicin—thyroid cancer	0.000457	0.00319	CcSEcCtD
Acetaminophen—Pruritus—Vandetanib—thyroid cancer	0.000454	0.00317	CcSEcCtD
Acetaminophen—Oliguria—Doxorubicin—thyroid cancer	0.00045	0.00315	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.000448	0.00314	CcSEcCtD
Acetaminophen—Hepatocellular injury—Epirubicin—thyroid cancer	0.000448	0.00314	CcSEcCtD
Acetaminophen—Injection site reaction—Epirubicin—thyroid cancer	0.000446	0.00312	CcSEcCtD
Acetaminophen—Dry mouth—Sorafenib—thyroid cancer	0.000442	0.00309	CcSEcCtD
Acetaminophen—Dyskinesia—Doxorubicin—thyroid cancer	0.000441	0.00309	CcSEcCtD
Acetaminophen—Eructation—Epirubicin—thyroid cancer	0.000441	0.00308	CcSEcCtD
Acetaminophen—Diarrhoea—Vandetanib—thyroid cancer	0.000439	0.00307	CcSEcCtD
Acetaminophen—Anaphylactic shock—Sorafenib—thyroid cancer	0.000433	0.00303	CcSEcCtD
Acetaminophen—Shock—Sorafenib—thyroid cancer	0.000426	0.00298	CcSEcCtD
Acetaminophen—Nervous system disorder—Sorafenib—thyroid cancer	0.000424	0.00297	CcSEcCtD
Acetaminophen—Dizziness—Vandetanib—thyroid cancer	0.000424	0.00297	CcSEcCtD
Acetaminophen—Thrombocytopenia—Sorafenib—thyroid cancer	0.000424	0.00296	CcSEcCtD
Acetaminophen—Coordination abnormal—Doxorubicin—thyroid cancer	0.000422	0.00295	CcSEcCtD
Acetaminophen—Skin disorder—Sorafenib—thyroid cancer	0.00042	0.00294	CcSEcCtD
Acetaminophen—Hepatocellular injury—Doxorubicin—thyroid cancer	0.000415	0.0029	CcSEcCtD
Acetaminophen—Anorexia—Sorafenib—thyroid cancer	0.000413	0.00288	CcSEcCtD
Acetaminophen—PTGS1—trachea—thyroid cancer	0.000413	0.017	CbGeAlD
Acetaminophen—Injection site reaction—Doxorubicin—thyroid cancer	0.000412	0.00288	CcSEcCtD
Acetaminophen—Coma—Epirubicin—thyroid cancer	0.00041	0.00286	CcSEcCtD
Acetaminophen—Vomiting—Vandetanib—thyroid cancer	0.000408	0.00285	CcSEcCtD
Acetaminophen—Eructation—Doxorubicin—thyroid cancer	0.000408	0.00285	CcSEcCtD
Acetaminophen—Rash maculo-papular—Epirubicin—thyroid cancer	0.000408	0.00285	CcSEcCtD
Acetaminophen—Rash—Vandetanib—thyroid cancer	0.000405	0.00283	CcSEcCtD
Acetaminophen—Dermatitis—Vandetanib—thyroid cancer	0.000404	0.00283	CcSEcCtD
Acetaminophen—Headache—Vandetanib—thyroid cancer	0.000402	0.00281	CcSEcCtD
Acetaminophen—Pulmonary oedema—Epirubicin—thyroid cancer	0.000399	0.00279	CcSEcCtD
Acetaminophen—PTGS2—trachea—thyroid cancer	0.000394	0.0163	CbGeAlD
Acetaminophen—Dyspnoea—Sorafenib—thyroid cancer	0.000386	0.0027	CcSEcCtD
Acetaminophen—Nausea—Vandetanib—thyroid cancer	0.000381	0.00267	CcSEcCtD
Acetaminophen—Dyspepsia—Sorafenib—thyroid cancer	0.000381	0.00266	CcSEcCtD
Acetaminophen—Coma—Doxorubicin—thyroid cancer	0.000379	0.00265	CcSEcCtD
Acetaminophen—Rash maculo-papular—Doxorubicin—thyroid cancer	0.000377	0.00264	CcSEcCtD
Acetaminophen—CYP1A2—thyroid gland—thyroid cancer	0.000377	0.0156	CbGeAlD
Acetaminophen—Decreased appetite—Sorafenib—thyroid cancer	0.000376	0.00263	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000374	0.00261	CcSEcCtD
Acetaminophen—Fatigue—Sorafenib—thyroid cancer	0.000373	0.00261	CcSEcCtD
Acetaminophen—Hepatic function abnormal—Epirubicin—thyroid cancer	0.000372	0.0026	CcSEcCtD
Acetaminophen—CYP1A1—thyroid gland—thyroid cancer	0.000371	0.0153	CbGeAlD
Acetaminophen—Photosensitivity—Epirubicin—thyroid cancer	0.000371	0.00259	CcSEcCtD
Acetaminophen—Constipation—Sorafenib—thyroid cancer	0.00037	0.00259	CcSEcCtD
Acetaminophen—Pulmonary oedema—Doxorubicin—thyroid cancer	0.000369	0.00258	CcSEcCtD
Acetaminophen—Hepatic failure—Epirubicin—thyroid cancer	0.000362	0.00253	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000354	0.00247	CcSEcCtD
Acetaminophen—Renal failure acute—Epirubicin—thyroid cancer	0.000353	0.00246	CcSEcCtD
Acetaminophen—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.000345	0.00241	CcSEcCtD
Acetaminophen—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.000345	0.00241	CcSEcCtD
Acetaminophen—Urticaria—Sorafenib—thyroid cancer	0.000344	0.0024	CcSEcCtD
Acetaminophen—Photosensitivity—Doxorubicin—thyroid cancer	0.000343	0.0024	CcSEcCtD
Acetaminophen—Abdominal pain—Sorafenib—thyroid cancer	0.000342	0.00239	CcSEcCtD
Acetaminophen—Body temperature increased—Sorafenib—thyroid cancer	0.000342	0.00239	CcSEcCtD
Acetaminophen—CYP2E1—thyroid gland—thyroid cancer	0.000339	0.014	CbGeAlD
Acetaminophen—Hepatic failure—Doxorubicin—thyroid cancer	0.000335	0.00234	CcSEcCtD
Acetaminophen—CYP1A1—head—thyroid cancer	0.00033	0.0136	CbGeAlD
Acetaminophen—PTGS1—thyroid gland—thyroid cancer	0.000326	0.0135	CbGeAlD
Acetaminophen—Renal failure acute—Doxorubicin—thyroid cancer	0.000326	0.00228	CcSEcCtD
Acetaminophen—Pain in extremity—Epirubicin—thyroid cancer	0.000325	0.00228	CcSEcCtD
Acetaminophen—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.000319	0.00223	CcSEcCtD
Acetaminophen—Hypersensitivity—Sorafenib—thyroid cancer	0.000319	0.00223	CcSEcCtD
Acetaminophen—Asthenia—Sorafenib—thyroid cancer	0.000311	0.00217	CcSEcCtD
Acetaminophen—Pruritus—Sorafenib—thyroid cancer	0.000306	0.00214	CcSEcCtD
Acetaminophen—Pain in extremity—Doxorubicin—thyroid cancer	0.000301	0.00211	CcSEcCtD
Acetaminophen—CYP2E1—head—thyroid cancer	0.000301	0.0124	CbGeAlD
Acetaminophen—Hypokalaemia—Epirubicin—thyroid cancer	0.000296	0.00207	CcSEcCtD
Acetaminophen—Diarrhoea—Sorafenib—thyroid cancer	0.000296	0.00207	CcSEcCtD
Acetaminophen—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000293	0.00205	CcSEcCtD
Acetaminophen—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000293	0.00205	CcSEcCtD
Acetaminophen—PTGS1—head—thyroid cancer	0.00029	0.012	CbGeAlD
Acetaminophen—Muscular weakness—Epirubicin—thyroid cancer	0.000287	0.00201	CcSEcCtD
Acetaminophen—Dizziness—Sorafenib—thyroid cancer	0.000286	0.002	CcSEcCtD
Acetaminophen—Abdominal distension—Epirubicin—thyroid cancer	0.000283	0.00198	CcSEcCtD
Acetaminophen—Asthma—Epirubicin—thyroid cancer	0.000281	0.00197	CcSEcCtD
Acetaminophen—PTGS2—head—thyroid cancer	0.000277	0.0114	CbGeAlD
Acetaminophen—Vomiting—Sorafenib—thyroid cancer	0.000275	0.00192	CcSEcCtD
Acetaminophen—Hypokalaemia—Doxorubicin—thyroid cancer	0.000274	0.00192	CcSEcCtD
Acetaminophen—Rash—Sorafenib—thyroid cancer	0.000273	0.00191	CcSEcCtD
Acetaminophen—Dermatitis—Sorafenib—thyroid cancer	0.000273	0.00191	CcSEcCtD
Acetaminophen—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000271	0.0019	CcSEcCtD
Acetaminophen—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000271	0.0019	CcSEcCtD
Acetaminophen—Headache—Sorafenib—thyroid cancer	0.000271	0.0019	CcSEcCtD
Acetaminophen—Pancytopenia—Epirubicin—thyroid cancer	0.000267	0.00187	CcSEcCtD
Acetaminophen—Muscular weakness—Doxorubicin—thyroid cancer	0.000266	0.00186	CcSEcCtD
Acetaminophen—Dysuria—Epirubicin—thyroid cancer	0.000263	0.00184	CcSEcCtD
Acetaminophen—Neutropenia—Epirubicin—thyroid cancer	0.000263	0.00184	CcSEcCtD
Acetaminophen—Abdominal distension—Doxorubicin—thyroid cancer	0.000262	0.00183	CcSEcCtD
Acetaminophen—Asthma—Doxorubicin—thyroid cancer	0.00026	0.00182	CcSEcCtD
Acetaminophen—Nausea—Sorafenib—thyroid cancer	0.000257	0.0018	CcSEcCtD
Acetaminophen—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000257	0.0018	CcSEcCtD
Acetaminophen—Hyperglycaemia—Epirubicin—thyroid cancer	0.000254	0.00177	CcSEcCtD
Acetaminophen—Drowsiness—Epirubicin—thyroid cancer	0.000251	0.00175	CcSEcCtD
Acetaminophen—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000249	0.00174	CcSEcCtD
Acetaminophen—Pancytopenia—Doxorubicin—thyroid cancer	0.000247	0.00173	CcSEcCtD
Acetaminophen—ABCB1—trachea—thyroid cancer	0.000244	0.0101	CbGeAlD
Acetaminophen—Neutropenia—Doxorubicin—thyroid cancer	0.000243	0.0017	CcSEcCtD
Acetaminophen—Dysuria—Doxorubicin—thyroid cancer	0.000243	0.0017	CcSEcCtD
Acetaminophen—Sweating—Epirubicin—thyroid cancer	0.00024	0.00168	CcSEcCtD
Acetaminophen—CYP2D6—head—thyroid cancer	0.000238	0.00983	CbGeAlD
Acetaminophen—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000238	0.00166	CcSEcCtD
Acetaminophen—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000237	0.00166	CcSEcCtD
Acetaminophen—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000235	0.00164	CcSEcCtD
Acetaminophen—Agranulocytosis—Epirubicin—thyroid cancer	0.000234	0.00164	CcSEcCtD
Acetaminophen—Drowsiness—Doxorubicin—thyroid cancer	0.000232	0.00162	CcSEcCtD
Acetaminophen—CYP1A1—lymph node—thyroid cancer	0.000231	0.00953	CbGeAlD
Acetaminophen—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.00023	0.00161	CcSEcCtD
Acetaminophen—Haemoglobin—Epirubicin—thyroid cancer	0.000226	0.00158	CcSEcCtD
Acetaminophen—Haemorrhage—Epirubicin—thyroid cancer	0.000225	0.00157	CcSEcCtD
Acetaminophen—Hepatitis—Epirubicin—thyroid cancer	0.000225	0.00157	CcSEcCtD
Acetaminophen—Sweating—Doxorubicin—thyroid cancer	0.000222	0.00156	CcSEcCtD
Acetaminophen—Urinary tract disorder—Epirubicin—thyroid cancer	0.000222	0.00155	CcSEcCtD
Acetaminophen—Oedema peripheral—Epirubicin—thyroid cancer	0.000222	0.00155	CcSEcCtD
Acetaminophen—Connective tissue disorder—Epirubicin—thyroid cancer	0.000221	0.00155	CcSEcCtD
Acetaminophen—Urethral disorder—Epirubicin—thyroid cancer	0.000221	0.00154	CcSEcCtD
Acetaminophen—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000219	0.00153	CcSEcCtD
Acetaminophen—Agranulocytosis—Doxorubicin—thyroid cancer	0.000217	0.00151	CcSEcCtD
Acetaminophen—Erythema multiforme—Epirubicin—thyroid cancer	0.000213	0.00149	CcSEcCtD
Acetaminophen—Eye disorder—Epirubicin—thyroid cancer	0.00021	0.00147	CcSEcCtD
Acetaminophen—Haemoglobin—Doxorubicin—thyroid cancer	0.000209	0.00146	CcSEcCtD
Acetaminophen—Cardiac disorder—Epirubicin—thyroid cancer	0.000209	0.00146	CcSEcCtD
Acetaminophen—Flushing—Epirubicin—thyroid cancer	0.000209	0.00146	CcSEcCtD
Acetaminophen—Haemorrhage—Doxorubicin—thyroid cancer	0.000208	0.00146	CcSEcCtD
Acetaminophen—Hepatitis—Doxorubicin—thyroid cancer	0.000208	0.00146	CcSEcCtD
Acetaminophen—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000206	0.00144	CcSEcCtD
Acetaminophen—Oedema peripheral—Doxorubicin—thyroid cancer	0.000205	0.00144	CcSEcCtD
Acetaminophen—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000205	0.00143	CcSEcCtD
Acetaminophen—Angiopathy—Epirubicin—thyroid cancer	0.000204	0.00143	CcSEcCtD
Acetaminophen—Urethral disorder—Doxorubicin—thyroid cancer	0.000204	0.00143	CcSEcCtD
Acetaminophen—Immune system disorder—Epirubicin—thyroid cancer	0.000203	0.00142	CcSEcCtD
Acetaminophen—Mediastinal disorder—Epirubicin—thyroid cancer	0.000203	0.00142	CcSEcCtD
Acetaminophen—PTGS1—lymph node—thyroid cancer	0.000203	0.00837	CbGeAlD
Acetaminophen—Chills—Epirubicin—thyroid cancer	0.000202	0.00141	CcSEcCtD
Acetaminophen—Mental disorder—Epirubicin—thyroid cancer	0.000197	0.00138	CcSEcCtD
Acetaminophen—Erythema multiforme—Doxorubicin—thyroid cancer	0.000197	0.00138	CcSEcCtD
Acetaminophen—Erythema—Epirubicin—thyroid cancer	0.000196	0.00137	CcSEcCtD
Acetaminophen—Malnutrition—Epirubicin—thyroid cancer	0.000196	0.00137	CcSEcCtD
Acetaminophen—Eye disorder—Doxorubicin—thyroid cancer	0.000195	0.00136	CcSEcCtD
Acetaminophen—PTGS2—lymph node—thyroid cancer	0.000194	0.008	CbGeAlD
Acetaminophen—Cardiac disorder—Doxorubicin—thyroid cancer	0.000193	0.00135	CcSEcCtD
Acetaminophen—Flushing—Doxorubicin—thyroid cancer	0.000193	0.00135	CcSEcCtD
Acetaminophen—ABCB1—thyroid gland—thyroid cancer	0.000193	0.00797	CbGeAlD
Acetaminophen—Tension—Epirubicin—thyroid cancer	0.000192	0.00134	CcSEcCtD
Acetaminophen—Nervousness—Epirubicin—thyroid cancer	0.00019	0.00133	CcSEcCtD
Acetaminophen—Angiopathy—Doxorubicin—thyroid cancer	0.000189	0.00132	CcSEcCtD
Acetaminophen—Muscle spasms—Epirubicin—thyroid cancer	0.000188	0.00132	CcSEcCtD
Acetaminophen—Immune system disorder—Doxorubicin—thyroid cancer	0.000188	0.00132	CcSEcCtD
Acetaminophen—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000188	0.00131	CcSEcCtD
Acetaminophen—Chills—Doxorubicin—thyroid cancer	0.000187	0.00131	CcSEcCtD
Acetaminophen—Vision blurred—Epirubicin—thyroid cancer	0.000185	0.00129	CcSEcCtD
Acetaminophen—Mental disorder—Doxorubicin—thyroid cancer	0.000183	0.00128	CcSEcCtD
Acetaminophen—Ill-defined disorder—Epirubicin—thyroid cancer	0.000182	0.00127	CcSEcCtD
Acetaminophen—Malnutrition—Doxorubicin—thyroid cancer	0.000181	0.00127	CcSEcCtD
Acetaminophen—Erythema—Doxorubicin—thyroid cancer	0.000181	0.00127	CcSEcCtD
Acetaminophen—Anaemia—Epirubicin—thyroid cancer	0.000181	0.00127	CcSEcCtD
Acetaminophen—Agitation—Epirubicin—thyroid cancer	0.00018	0.00126	CcSEcCtD
Acetaminophen—Tension—Doxorubicin—thyroid cancer	0.000178	0.00124	CcSEcCtD
Acetaminophen—Malaise—Epirubicin—thyroid cancer	0.000177	0.00124	CcSEcCtD
Acetaminophen—Nervousness—Doxorubicin—thyroid cancer	0.000176	0.00123	CcSEcCtD
Acetaminophen—Leukopenia—Epirubicin—thyroid cancer	0.000175	0.00123	CcSEcCtD
Acetaminophen—Muscle spasms—Doxorubicin—thyroid cancer	0.000174	0.00122	CcSEcCtD
Acetaminophen—Palpitations—Epirubicin—thyroid cancer	0.000173	0.00121	CcSEcCtD
Acetaminophen—ABCB1—head—thyroid cancer	0.000171	0.00707	CbGeAlD
Acetaminophen—Cough—Epirubicin—thyroid cancer	0.000171	0.0012	CcSEcCtD
Acetaminophen—Vision blurred—Doxorubicin—thyroid cancer	0.000171	0.0012	CcSEcCtD
Acetaminophen—Convulsion—Epirubicin—thyroid cancer	0.00017	0.00119	CcSEcCtD
Acetaminophen—Hypertension—Epirubicin—thyroid cancer	0.000169	0.00118	CcSEcCtD
Acetaminophen—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000168	0.00118	CcSEcCtD
Acetaminophen—Anaemia—Doxorubicin—thyroid cancer	0.000168	0.00117	CcSEcCtD
Acetaminophen—Chest pain—Epirubicin—thyroid cancer	0.000167	0.00117	CcSEcCtD
Acetaminophen—Agitation—Doxorubicin—thyroid cancer	0.000167	0.00117	CcSEcCtD
Acetaminophen—Anxiety—Epirubicin—thyroid cancer	0.000166	0.00116	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000166	0.00116	CcSEcCtD
Acetaminophen—Discomfort—Epirubicin—thyroid cancer	0.000165	0.00115	CcSEcCtD
Acetaminophen—Malaise—Doxorubicin—thyroid cancer	0.000164	0.00114	CcSEcCtD
Acetaminophen—Dry mouth—Epirubicin—thyroid cancer	0.000163	0.00114	CcSEcCtD
Acetaminophen—Leukopenia—Doxorubicin—thyroid cancer	0.000162	0.00114	CcSEcCtD
Acetaminophen—Confusional state—Epirubicin—thyroid cancer	0.000161	0.00113	CcSEcCtD
Acetaminophen—Palpitations—Doxorubicin—thyroid cancer	0.00016	0.00112	CcSEcCtD
Acetaminophen—Anaphylactic shock—Epirubicin—thyroid cancer	0.00016	0.00112	CcSEcCtD
Acetaminophen—Oedema—Epirubicin—thyroid cancer	0.00016	0.00112	CcSEcCtD
Acetaminophen—Cough—Doxorubicin—thyroid cancer	0.000158	0.00111	CcSEcCtD
Acetaminophen—Shock—Epirubicin—thyroid cancer	0.000157	0.0011	CcSEcCtD
Acetaminophen—Convulsion—Doxorubicin—thyroid cancer	0.000157	0.0011	CcSEcCtD
Acetaminophen—Nervous system disorder—Epirubicin—thyroid cancer	0.000157	0.0011	CcSEcCtD
Acetaminophen—Thrombocytopenia—Epirubicin—thyroid cancer	0.000157	0.0011	CcSEcCtD
Acetaminophen—Hypertension—Doxorubicin—thyroid cancer	0.000157	0.00109	CcSEcCtD
Acetaminophen—Tachycardia—Epirubicin—thyroid cancer	0.000156	0.00109	CcSEcCtD
Acetaminophen—Skin disorder—Epirubicin—thyroid cancer	0.000155	0.00109	CcSEcCtD
Acetaminophen—Hyperhidrosis—Epirubicin—thyroid cancer	0.000155	0.00108	CcSEcCtD
Acetaminophen—Chest pain—Doxorubicin—thyroid cancer	0.000154	0.00108	CcSEcCtD
Acetaminophen—Anxiety—Doxorubicin—thyroid cancer	0.000154	0.00108	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000153	0.00107	CcSEcCtD
Acetaminophen—Discomfort—Doxorubicin—thyroid cancer	0.000153	0.00107	CcSEcCtD
Acetaminophen—Anorexia—Epirubicin—thyroid cancer	0.000152	0.00107	CcSEcCtD
Acetaminophen—Dry mouth—Doxorubicin—thyroid cancer	0.000151	0.00106	CcSEcCtD
Acetaminophen—Hypotension—Epirubicin—thyroid cancer	0.000149	0.00105	CcSEcCtD
Acetaminophen—Confusional state—Doxorubicin—thyroid cancer	0.000149	0.00104	CcSEcCtD
Acetaminophen—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000148	0.00103	CcSEcCtD
Acetaminophen—Oedema—Doxorubicin—thyroid cancer	0.000148	0.00103	CcSEcCtD
Acetaminophen—Shock—Doxorubicin—thyroid cancer	0.000146	0.00102	CcSEcCtD
Acetaminophen—Nervous system disorder—Doxorubicin—thyroid cancer	0.000145	0.00101	CcSEcCtD
Acetaminophen—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000145	0.00101	CcSEcCtD
Acetaminophen—Insomnia—Epirubicin—thyroid cancer	0.000145	0.00101	CcSEcCtD
Acetaminophen—Tachycardia—Doxorubicin—thyroid cancer	0.000144	0.00101	CcSEcCtD
Acetaminophen—Skin disorder—Doxorubicin—thyroid cancer	0.000144	0.00101	CcSEcCtD
Acetaminophen—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000143	0.001	CcSEcCtD
Acetaminophen—Dyspnoea—Epirubicin—thyroid cancer	0.000143	0.000997	CcSEcCtD
Acetaminophen—Somnolence—Epirubicin—thyroid cancer	0.000142	0.000994	CcSEcCtD
Acetaminophen—Anorexia—Doxorubicin—thyroid cancer	0.000141	0.000987	CcSEcCtD
Acetaminophen—Dyspepsia—Epirubicin—thyroid cancer	0.000141	0.000985	CcSEcCtD
Acetaminophen—Decreased appetite—Epirubicin—thyroid cancer	0.000139	0.000972	CcSEcCtD
Acetaminophen—Hypotension—Doxorubicin—thyroid cancer	0.000138	0.000967	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000138	0.000966	CcSEcCtD
Acetaminophen—Fatigue—Epirubicin—thyroid cancer	0.000138	0.000964	CcSEcCtD
Acetaminophen—Constipation—Epirubicin—thyroid cancer	0.000137	0.000956	CcSEcCtD
Acetaminophen—Insomnia—Doxorubicin—thyroid cancer	0.000134	0.000936	CcSEcCtD
Acetaminophen—Dyspnoea—Doxorubicin—thyroid cancer	0.000132	0.000923	CcSEcCtD
Acetaminophen—Feeling abnormal—Epirubicin—thyroid cancer	0.000132	0.000922	CcSEcCtD
Acetaminophen—Somnolence—Doxorubicin—thyroid cancer	0.000132	0.00092	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000131	0.000915	CcSEcCtD
Acetaminophen—Dyspepsia—Doxorubicin—thyroid cancer	0.00013	0.000911	CcSEcCtD
Acetaminophen—Decreased appetite—Doxorubicin—thyroid cancer	0.000129	0.0009	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000128	0.000893	CcSEcCtD
Acetaminophen—Fatigue—Doxorubicin—thyroid cancer	0.000128	0.000892	CcSEcCtD
Acetaminophen—Urticaria—Epirubicin—thyroid cancer	0.000127	0.000889	CcSEcCtD
Acetaminophen—Constipation—Doxorubicin—thyroid cancer	0.000127	0.000885	CcSEcCtD
Acetaminophen—Abdominal pain—Epirubicin—thyroid cancer	0.000126	0.000884	CcSEcCtD
Acetaminophen—Body temperature increased—Epirubicin—thyroid cancer	0.000126	0.000884	CcSEcCtD
Acetaminophen—Feeling abnormal—Doxorubicin—thyroid cancer	0.000122	0.000853	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000121	0.000846	CcSEcCtD
Acetaminophen—ABCB1—lymph node—thyroid cancer	0.00012	0.00495	CbGeAlD
Acetaminophen—Hypersensitivity—Epirubicin—thyroid cancer	0.000118	0.000824	CcSEcCtD
Acetaminophen—Urticaria—Doxorubicin—thyroid cancer	0.000118	0.000822	CcSEcCtD
Acetaminophen—Abdominal pain—Doxorubicin—thyroid cancer	0.000117	0.000818	CcSEcCtD
Acetaminophen—Body temperature increased—Doxorubicin—thyroid cancer	0.000117	0.000818	CcSEcCtD
Acetaminophen—Asthenia—Epirubicin—thyroid cancer	0.000115	0.000803	CcSEcCtD
Acetaminophen—Pruritus—Epirubicin—thyroid cancer	0.000113	0.000791	CcSEcCtD
Acetaminophen—Diarrhoea—Epirubicin—thyroid cancer	0.000109	0.000765	CcSEcCtD
Acetaminophen—Hypersensitivity—Doxorubicin—thyroid cancer	0.000109	0.000763	CcSEcCtD
Acetaminophen—Asthenia—Doxorubicin—thyroid cancer	0.000106	0.000743	CcSEcCtD
Acetaminophen—Dizziness—Epirubicin—thyroid cancer	0.000106	0.00074	CcSEcCtD
Acetaminophen—Pruritus—Doxorubicin—thyroid cancer	0.000105	0.000732	CcSEcCtD
Acetaminophen—Vomiting—Epirubicin—thyroid cancer	0.000102	0.000711	CcSEcCtD
Acetaminophen—Diarrhoea—Doxorubicin—thyroid cancer	0.000101	0.000708	CcSEcCtD
Acetaminophen—Rash—Epirubicin—thyroid cancer	0.000101	0.000705	CcSEcCtD
Acetaminophen—Dermatitis—Epirubicin—thyroid cancer	0.000101	0.000705	CcSEcCtD
Acetaminophen—Headache—Epirubicin—thyroid cancer	0.0001	0.000701	CcSEcCtD
Acetaminophen—Dizziness—Doxorubicin—thyroid cancer	9.79e-05	0.000684	CcSEcCtD
Acetaminophen—Nausea—Epirubicin—thyroid cancer	9.5e-05	0.000664	CcSEcCtD
Acetaminophen—Vomiting—Doxorubicin—thyroid cancer	9.41e-05	0.000658	CcSEcCtD
Acetaminophen—Rash—Doxorubicin—thyroid cancer	9.33e-05	0.000653	CcSEcCtD
Acetaminophen—Dermatitis—Doxorubicin—thyroid cancer	9.32e-05	0.000652	CcSEcCtD
Acetaminophen—Headache—Doxorubicin—thyroid cancer	9.27e-05	0.000648	CcSEcCtD
Acetaminophen—Nausea—Doxorubicin—thyroid cancer	8.79e-05	0.000615	CcSEcCtD
Acetaminophen—CNR1—Signaling Pathways—CDK1—thyroid cancer	5.71e-05	0.000611	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	5.68e-05	0.000608	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—NDUFA13—thyroid cancer	5.65e-05	0.000604	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—CCND1—thyroid cancer	5.49e-05	0.000587	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	5.44e-05	0.000582	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—MINPP1—thyroid cancer	5.41e-05	0.000578	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—HPGD—thyroid cancer	5.39e-05	0.000577	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—RXRA—thyroid cancer	5.39e-05	0.000576	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.37e-05	0.000574	CbGpPWpGaD
Acetaminophen—PTGS2—C-MYB transcription factor network—KRAS—thyroid cancer	5.34e-05	0.000571	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—NDUFA13—thyroid cancer	5.32e-05	0.000569	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—CHST14—thyroid cancer	5.31e-05	0.000568	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—PPARG—thyroid cancer	5.28e-05	0.000565	CbGpPWpGaD
Acetaminophen—SLC22A6—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.14e-05	0.00055	CbGpPWpGaD
Acetaminophen—CYP1A2—Biological oxidations—RXRA—thyroid cancer	5.12e-05	0.000547	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—HPGD—thyroid cancer	5.1e-05	0.000545	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—NDUFA13—thyroid cancer	5.02e-05	0.000536	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—CHST14—thyroid cancer	5e-05	0.000535	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	4.89e-05	0.000523	CbGpPWpGaD
Acetaminophen—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—thyroid cancer	4.89e-05	0.000523	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—PTGS2—thyroid cancer	4.72e-05	0.000505	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—CHST14—thyroid cancer	4.72e-05	0.000504	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—MINPP1—thyroid cancer	4.71e-05	0.000504	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—NDUFA13—thyroid cancer	4.6e-05	0.000492	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—NRG1—thyroid cancer	4.58e-05	0.00049	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—PPARG—thyroid cancer	4.55e-05	0.000486	CbGpPWpGaD
Acetaminophen—PTGS2—C-MYB transcription factor network—HRAS—thyroid cancer	4.54e-05	0.000485	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—MINPP1—thyroid cancer	4.44e-05	0.000475	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—MINPP1—thyroid cancer	4.4e-05	0.000471	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.38e-05	0.000468	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—PPARG—thyroid cancer	4.34e-05	0.000464	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—CHST14—thyroid cancer	4.32e-05	0.000462	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—HPGD—thyroid cancer	4.28e-05	0.000458	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	4.16e-05	0.000444	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—PTGS2—thyroid cancer	4.16e-05	0.000444	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—TERT—thyroid cancer	4.12e-05	0.00044	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—PTEN—thyroid cancer	4.12e-05	0.00044	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—PPARG—thyroid cancer	4.08e-05	0.000436	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—HPGD—thyroid cancer	4.03e-05	0.000431	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—TCF7L1—thyroid cancer	4.01e-05	0.000429	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—NDUFA13—thyroid cancer	4.01e-05	0.000428	CbGpPWpGaD
Acetaminophen—CYP3A4—Biological oxidations—RXRA—thyroid cancer	3.95e-05	0.000422	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—HIF1A—thyroid cancer	3.94e-05	0.000421	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—TPR—thyroid cancer	3.8e-05	0.000406	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—HPGD—thyroid cancer	3.8e-05	0.000406	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—TPR—thyroid cancer	3.8e-05	0.000406	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—NDUFA13—thyroid cancer	3.77e-05	0.000404	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—CHST14—thyroid cancer	3.77e-05	0.000403	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—MINPP1—thyroid cancer	3.76e-05	0.000402	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—NDUFA13—thyroid cancer	3.74e-05	0.0004	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PRKAR1A—thyroid cancer	3.74e-05	0.0004	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PRKAR1A—thyroid cancer	3.74e-05	0.0004	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	3.73e-05	0.000399	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	3.72e-05	0.000398	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	3.72e-05	0.000398	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	3.66e-05	0.000392	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—PTEN—thyroid cancer	3.62e-05	0.000387	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—TP53—thyroid cancer	3.62e-05	0.000387	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	3.6e-05	0.000385	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—PTGS2—thyroid cancer	3.58e-05	0.000382	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—CHST14—thyroid cancer	3.55e-05	0.000379	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—CHST14—thyroid cancer	3.52e-05	0.000376	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—HPGD—thyroid cancer	3.48e-05	0.000373	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.47e-05	0.000371	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—NRAS—thyroid cancer	3.47e-05	0.000371	CbGpPWpGaD
Acetaminophen—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	3.44e-05	0.000368	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—PTGS2—thyroid cancer	3.41e-05	0.000365	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—PPARG—thyroid cancer	3.4e-05	0.000364	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.39e-05	0.000362	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—BRAF—thyroid cancer	3.26e-05	0.000349	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—PTGS2—thyroid cancer	3.21e-05	0.000343	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—NDUFA13—thyroid cancer	3.2e-05	0.000342	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—PTEN—thyroid cancer	3.12e-05	0.000334	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—TPR—thyroid cancer	3.1e-05	0.000331	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.08e-05	0.00033	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PRKAR1A—thyroid cancer	3.05e-05	0.000326	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—HPGD—thyroid cancer	3.04e-05	0.000325	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—CHST14—thyroid cancer	3.01e-05	0.000321	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—KRAS—thyroid cancer	2.98e-05	0.000319	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—PTEN—thyroid cancer	2.98e-05	0.000318	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—TPR—thyroid cancer	2.94e-05	0.000314	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—TPR—thyroid cancer	2.93e-05	0.000313	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	2.93e-05	0.000313	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—MINPP1—thyroid cancer	2.9e-05	0.00031	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—PRKAR1A—thyroid cancer	2.89e-05	0.000309	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PRKAR1A—thyroid cancer	2.88e-05	0.000308	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—HPGD—thyroid cancer	2.86e-05	0.000306	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—SLC5A5—thyroid cancer	2.85e-05	0.000304	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—SLC5A5—thyroid cancer	2.85e-05	0.000304	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—HPGD—thyroid cancer	2.84e-05	0.000303	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.83e-05	0.000302	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—PTEN—thyroid cancer	2.8e-05	0.000299	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.79e-05	0.000298	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	2.77e-05	0.000296	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.76e-05	0.000295	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—MEN1—thyroid cancer	2.76e-05	0.000295	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—PTGS2—thyroid cancer	2.68e-05	0.000286	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.67e-05	0.000285	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	2.65e-05	0.000283	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	2.55e-05	0.000273	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—HRAS—thyroid cancer	2.54e-05	0.000271	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—NDUFA13—thyroid cancer	2.47e-05	0.000264	CbGpPWpGaD
Acetaminophen—CNR1—GPCR downstream signaling—AKT1—thyroid cancer	2.47e-05	0.000264	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—TPR—thyroid cancer	2.46e-05	0.000263	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	2.46e-05	0.000263	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—HPGD—thyroid cancer	2.42e-05	0.000259	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—PRKAR1A—thyroid cancer	2.42e-05	0.000259	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—RXRA—thyroid cancer	2.39e-05	0.000256	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—RXRA—thyroid cancer	2.39e-05	0.000256	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—CCND1—thyroid cancer	2.38e-05	0.000254	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—AKT1—thyroid cancer	2.37e-05	0.000254	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.34e-05	0.00025	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—PTEN—thyroid cancer	2.34e-05	0.00025	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.33e-05	0.000249	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—CHST14—thyroid cancer	2.32e-05	0.000248	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—SLC5A5—thyroid cancer	2.32e-05	0.000248	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—TPR—thyroid cancer	2.32e-05	0.000248	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.3e-05	0.000246	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—PTEN—thyroid cancer	2.3e-05	0.000246	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PRKAR1A—thyroid cancer	2.28e-05	0.000244	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—AKT1—thyroid cancer	2.24e-05	0.00024	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—CALCA—thyroid cancer	2.2e-05	0.000235	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—SLC5A5—thyroid cancer	2.19e-05	0.000235	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.19e-05	0.000235	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—TPR—thyroid cancer	2.18e-05	0.000233	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.17e-05	0.000232	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PRKAR1A—thyroid cancer	2.15e-05	0.00023	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—AKT1—thyroid cancer	2.09e-05	0.000223	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	2.08e-05	0.000222	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—NRAS—thyroid cancer	2.05e-05	0.000219	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—TPR—thyroid cancer	2e-05	0.000214	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—CDK1—thyroid cancer	1.99e-05	0.000213	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	1.97e-05	0.000211	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.97e-05	0.00021	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	1.96e-05	0.00021	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—RXRA—thyroid cancer	1.95e-05	0.000208	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.95e-05	0.000208	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.9e-05	0.000203	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—HPGD—thyroid cancer	1.87e-05	0.0002	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—RXRA—thyroid cancer	1.84e-05	0.000197	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—SLC5A5—thyroid cancer	1.84e-05	0.000197	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—AKT1—thyroid cancer	1.8e-05	0.000192	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.78e-05	0.000191	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—KRAS—thyroid cancer	1.76e-05	0.000189	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—TPR—thyroid cancer	1.74e-05	0.000186	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.74e-05	0.000186	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—SLC5A5—thyroid cancer	1.73e-05	0.000185	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PRKAR1A—thyroid cancer	1.72e-05	0.000183	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—AKT1—thyroid cancer	1.72e-05	0.000183	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—TPR—thyroid cancer	1.64e-05	0.000176	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—SLC5A5—thyroid cancer	1.63e-05	0.000175	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—TPR—thyroid cancer	1.63e-05	0.000174	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	1.62e-05	0.000173	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—AKT1—thyroid cancer	1.61e-05	0.000172	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	1.6e-05	0.000171	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—NRG1—thyroid cancer	1.6e-05	0.000171	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—TP53—thyroid cancer	1.57e-05	0.000168	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—RXRA—thyroid cancer	1.55e-05	0.000165	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.53e-05	0.000164	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PPARG—thyroid cancer	1.51e-05	0.000161	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PPARG—thyroid cancer	1.51e-05	0.000161	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.5e-05	0.000161	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—HRAS—thyroid cancer	1.5e-05	0.00016	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—SLC5A5—thyroid cancer	1.5e-05	0.00016	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.47e-05	0.000157	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—RXRA—thyroid cancer	1.46e-05	0.000156	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.45e-05	0.000155	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—TERT—thyroid cancer	1.43e-05	0.000153	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.4e-05	0.00015	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—TPR—thyroid cancer	1.39e-05	0.000149	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—RXRA—thyroid cancer	1.37e-05	0.000147	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—HIF1A—thyroid cancer	1.37e-05	0.000147	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	1.37e-05	0.000146	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—AKT1—thyroid cancer	1.35e-05	0.000144	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.34e-05	0.000143	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—AKT1—thyroid cancer	1.32e-05	0.000142	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—SLC5A5—thyroid cancer	1.31e-05	0.00014	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—RXRA—thyroid cancer	1.26e-05	0.000135	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.24e-05	0.000133	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PPARG—thyroid cancer	1.23e-05	0.000132	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—SLC5A5—thyroid cancer	1.23e-05	0.000132	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.22e-05	0.000131	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—SLC5A5—thyroid cancer	1.22e-05	0.00013	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PTGS2—thyroid cancer	1.19e-05	0.000127	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PTGS2—thyroid cancer	1.19e-05	0.000127	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PPARG—thyroid cancer	1.16e-05	0.000124	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.14e-05	0.000122	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—BRAF—thyroid cancer	1.14e-05	0.000121	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—RXRA—thyroid cancer	1.1e-05	0.000117	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—TPR—thyroid cancer	1.07e-05	0.000115	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.06e-05	0.000113	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—SLC5A5—thyroid cancer	1.04e-05	0.000111	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PTEN—thyroid cancer	1.04e-05	0.000111	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PTEN—thyroid cancer	1.04e-05	0.000111	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—RXRA—thyroid cancer	1.03e-05	0.00011	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—RXRA—thyroid cancer	1.02e-05	0.00011	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.96e-06	0.000107	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—PPARG—thyroid cancer	9.77e-06	0.000104	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	9.76e-06	0.000104	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PTGS2—thyroid cancer	9.68e-06	0.000103	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PPARG—thyroid cancer	9.2e-06	9.83e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PTGS2—thyroid cancer	9.15e-06	9.79e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—RXRA—thyroid cancer	8.75e-06	9.36e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PPARG—thyroid cancer	8.67e-06	9.27e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	8.52e-06	9.1e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PTEN—thyroid cancer	8.44e-06	9.03e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—SLC5A5—thyroid cancer	8.04e-06	8.6e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—PTEN—thyroid cancer	8e-06	8.56e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PTEN—thyroid cancer	7.98e-06	8.53e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PPARG—thyroid cancer	7.95e-06	8.5e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PTGS2—thyroid cancer	7.23e-06	7.73e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—NRAS—thyroid cancer	7.14e-06	7.63e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PPARG—thyroid cancer	6.92e-06	7.4e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PTGS2—thyroid cancer	6.82e-06	7.29e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—RXRA—thyroid cancer	6.76e-06	7.22e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—PTEN—thyroid cancer	6.7e-06	7.17e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PPARG—thyroid cancer	6.53e-06	6.98e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PPARG—thyroid cancer	6.47e-06	6.92e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PTEN—thyroid cancer	6.31e-06	6.74e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PTGS2—thyroid cancer	6.25e-06	6.69e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—KRAS—thyroid cancer	6.14e-06	6.57e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—AKT1—thyroid cancer	5.97e-06	6.38e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—AKT1—thyroid cancer	5.97e-06	6.38e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PTEN—thyroid cancer	5.95e-06	6.36e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PPARG—thyroid cancer	5.53e-06	5.91e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PTEN—thyroid cancer	5.45e-06	5.83e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PTGS2—thyroid cancer	5.45e-06	5.82e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—HRAS—thyroid cancer	5.22e-06	5.58e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PTGS2—thyroid cancer	5.13e-06	5.49e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PTGS2—thyroid cancer	5.09e-06	5.44e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—AKT1—thyroid cancer	4.86e-06	5.2e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PTEN—thyroid cancer	4.75e-06	5.08e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—AKT1—thyroid cancer	4.61e-06	4.93e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—AKT1—thyroid cancer	4.6e-06	4.92e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PTEN—thyroid cancer	4.48e-06	4.79e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PTEN—thyroid cancer	4.44e-06	4.74e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PTGS2—thyroid cancer	4.35e-06	4.65e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PPARG—thyroid cancer	4.27e-06	4.56e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—AKT1—thyroid cancer	3.86e-06	4.13e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PTEN—thyroid cancer	3.79e-06	4.05e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—AKT1—thyroid cancer	3.64e-06	3.89e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—AKT1—thyroid cancer	3.43e-06	3.66e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PTGS2—thyroid cancer	3.36e-06	3.59e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—AKT1—thyroid cancer	3.14e-06	3.36e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PTEN—thyroid cancer	2.93e-06	3.13e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—AKT1—thyroid cancer	2.74e-06	2.93e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—AKT1—thyroid cancer	2.58e-06	2.76e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—AKT1—thyroid cancer	2.56e-06	2.73e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—AKT1—thyroid cancer	2.19e-06	2.34e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—AKT1—thyroid cancer	1.69e-06	1.8e-05	CbGpPWpGaD
